Latest News & Features

Reset all filters
Article Type
Channels & Sectors
Geography
Company
Refine Search
Astellas doubles down on gene therapy with $3bn Audentes deal
Americas
Astellas is set to buy US-based Audentes Therapeutics for approximately $3 billion, as the Japanese pharmaceutical company looks to boost its gene therapy expertise.   5 December 2019
Barnes & Thornburg adds 17, creates three new offices
Americas
Barnes & Thornburg has recruited a new life sciences patent group from the IP boutique Brinks, Gilson & Lione.   3 December 2019
US considers shortening marketing exclusivity to push forward USMCA
Big Pharma
The Trump administration is considering shortening the period that big pharma companies’ biologic drugs are protected by marketing exclusivity from biosimilar competition.   3 December 2019
Americas
Genus Lifesciences is suing pharmaceutical company Mallinckrodt for misusing trade secrets related to a cocaine hydrochloride formulation.   3 December 2019
Americas
California-based Bio-Rad Laboratories has obtained an injunction from a German court in its long-running dispute with US biotechnology company 10x Genomics.   3 December 2019
Big Pharma
China has added 70 medicines to its national medical insurance catalogue, which will reduce the cost of the drugs by more than 60% on average, the National Healthcare Security Administration has said.   2 December 2019
Big Pharma
Japanese pharmaceutical conglomerate Asahi Kasei has announced it will acquire Danish company Veloxis Pharmaceuticals for $1.3 billion.   28 November 2019
Big Pharma
Amgen and Coherus Biosciences have settled a patent infringement dispute, after Coherus claimed that Amgen was infringing three of its patents.   28 November 2019
Medtech
A US district court has partially granted medical devices maker Nevro’s motion to dismiss patent infringement claims against the company by a competitor, Boston Scientific.   28 November 2019
Asia
The Japan Patent Office and the Intellectual Property Office of Singapore have each granted Merck KGaA a patent covering the use of paired CRISPR nickases.   27 November 2019